建議

本研究因AMD 患者的數目並不足以將 AMD 族群進一步的區分為 dry AMD 和 wet AMD 兩種表現型，所以將所有的 AMD 患者的報告結果一起分析，此外，有些 SNP 基因型分佈機率相當的罕見，所以需要更大的樣本數來加以確認實驗的結果，

並且也可以將AMD 患者區分為 dry AMD 和 wet AMD 兩種表現型來觀察這些基因之 多型性在兩族群之間的分佈是否有所差異存在。進一步的研究，可測定這些實驗對

象，其血清中 VEGF，TNF-α 及其他細胞激素的濃度來證明我們的推測是否正確，

未來，可進一步地研究這些基因在眼球組織的表現，如轉錄的速率，mRNA 的穩定

性及蛋白質的表現等等，以更了解AMD 致病機轉，尋求更有效的預防及治療方式。

References

1.Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study.

Arch Ophthalmol 1998;116:653-658.

2.McConnell V, Silvestri G. Age-related macular degeneration. Ulster Med J 2005;

74:82-92.

3.Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227-253.

4.Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257-293.

5.Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA, Eastman CG, Casavant TL, Sheffield VC. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 2004;351:346-353.

6.Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, Dean M, Lupski JR, Leppert M. Mutation of the stargardt disease gene (ABCR) in age-related macular degeneration . Science 1997;

277:1805-1807.

7.Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy.

Am J Ophthalmol 1997;123:199-206.

8.Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: The beaver dam eye study. Ophthalmol 1992;99:933-943.

9.Tanemura M, Miyamoto N, Mandai M, Honda Y. Estrogen may enhance VEGFR-2 expression in the process of laser-induced CNV formation. Invest Ophthalmol Vis Sci 2001;421:S96

10.Friedman DS, Katz J, Bressler NM, Rahmani B , Tielsch, JM. Racial differences in the prevalence of age-related macular degeneration: The baltimore eye survey. Ophthalmology 1999;106:1049-1055.

11.Klein R, Klein BE, Marino EK, Kuller LH, Furberg C. Burke GL, Hubbard LD. Early age-related maculopathy in the cardiovascular health study. Ophthalmology 2003;110:25-33.

12.Sundelin SP, Nilsson SE, Brunk UT. Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content. Free Radic Biol Med 2001;30:74-81.

13.Kayatz P, Thumann G, Luther TT, Jordan JF, Bartz-Schmidt KU, Esser PJ, Schraermeyer U. Oxidation causes melanin fluorescence. Invest Ophthalmol Vis Sci 2001;42:241-246.

14.Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study.Pathologies Oculaires liees a l'age. Arch. Ophthalmol 1998;116:1031-1035

15.Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-839.

16.Hyman L, Schachat AP, He Q, Leske MC. Hypertension,cardiovascular disease, and age-related macular degeneration. Age-related macular degeneration risk factors study group. Arch Ophthalmol 2000;118:351-358.

17.Otani A, Takagi H, Oh H, Koyama S, Honda Y. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 2001;50:867-875.

18.Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM. Klein BE, Palta M.

Dietary fat and age-related maculopathy. Arch. Ophthalmol 1995;113: 743-748.

19.Young RW. Solar radiation and age-related macular degeneration. Surv. Ophthalmol 1988;32:252-269.

20.Smith W, Mitchell P. Family history and age-related maculopathy: The blue mountains eye study. Aust. N. Z. J. Ophthalmol. 1998;26:203-206.

21.Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism in agerelated macular degeneration. Science 2005;308:421-424.

22.Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration.The International ABCR Screening Consortium. Am J Human Genet 2000; 67: 487-91.Epub 2000 Jul 3.

23.Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA,Eastman CG, Casavant TL, Sheffield VC. Missense variations in the fibulin 5 gene and age-related macular degeneration. The N Engl J Med 2004;351:346-353.

24.Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Sur Opthalmol 2000;45:115-134.

25.Sundelin SP, Wihlmark U, Nilsson SEG, Brunk UT. Lipofuscin accumulation in cultured retinal pigment epithelial cells reduces their phagocytic capacity. Curr Eye Res 1998;17:851-857.

26.Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PGH, de Jong PTVM. Morphometric analysis of Bruch’s membrane, the choriocapillaris and the choroid in ageing. Invest Ophthalmol Vis Sci. 1994;35:2857-2864.

27.Hewitt AT, Nakazawa K, Newsome DA. Analysis of newly synthesized bruch's membrane proteoglycans. Invest Ophthalmol Vis Sci 1989;30:478-486.

28.Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration.

Arch Ophthalmol 2004;122:598-614.

29.Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins [review]. Am J Clin Nutr 1995;62(6 suppl):

1448S-1461S.

30.Cohen SM, Olin KL, Feuer WJ, Hjelmeland L, Keen CL, Morse LS. Low glutathione reductase and peroxidase activity in age-related macular degeneration. Br J Ophthalmol 1994;78:791-794.

31.Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Res 1992;13:18.

32.Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.

33.Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.

34.Gilbert SF. 2000. Formation of blood vessels, developmental biology. 6th ed.

Sunderland (MA): Sinauer Associates, Inc.

35.Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1(ICAM-1). Am J Pathol 2000;156:1733-1739.

36.Taichman NS, Young S, Cruchley AT, Taylor P, Paleolog E. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 1997;62:397-400.

37.Uhlmann S, Friedrichs U, Eichler W, Hoffmann S, Wiedemann P. Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells. Microvasc Res 2001;62:179-189.

38.Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, Billiar T R.Shears, L. L., 2nd. Nitric oxide induces angiogenesis and upregulates αvβ3 integrin expression on endothelial cells. Microvasc Res 2000;60:269-280.

39.Dulak J, Jozkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, Wojtowicz A, Szuba A, Cooke, JP. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells.

Arterioscler Thromb Vasc Biol 2000;20:659-666.

40.Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992;153:557-562.

41.Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314:992-993.

42.Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am. J. Pathol. 2000;157:135-144.

43.Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch. Clin Exp Ophthalmol. 1997;235:159-167.

44.Rajashekhar G, Willuweit A, Patterson CE, Sun P, Hilbig A, Breier G, Helisch A, Clauss M. Continuous endothelial cell activation increases angiogenesis: Evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res 2006;43:193-204.

45.Ferrara N. Vascular endothelial growth factor and the regulaion of angiogenesis. Recent Prog Horm Res 2000;55:15-35.

46.Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.

Oncogene 2003;22:1517-1527.

47.Klagsbrun M, D’Amore P. Vascular endothelial growth factor and its receptors. Cyt Growth Factor Rev 1996;7:259-270

48.Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, Maruo T. The tumor necrosis factor-α promoter -1031C polymorphism is associated with decreased risk of endometriosis in a japanese population.

Hum Reprod 2004;19:2509-2514.

49.Schruefer R, Lutze N, Schymeinsky J, Walzog B. Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8.

Am J Physiol Heart Circ Physiol 2005;228:H1186-1192.

50.Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231.

51.Soubrane G, Bressler NM. Treatment of subfoveal choroidal neovascularisation in age-related macular degeneration: Focus on clinical application of verteporfin photodynamic therapy. Br J Ophthalmol 2001;85:483-495.

52.Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-1249.

53.Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996;93:1493-1495.

54.Perrin RM, Konopatskaya O, Qiu Y, Harper S,Bates DO, Churchill AJ. Diabetic retinopathy is associated with a switch in splicing from anti- to pro- angiogenic isoforms of vascular endothelial growth factor. Diabetologia 2005;48:2422-2427.

55.Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT. Increased expression of angiogenic growth factors in age-related maculopathy. Br. J. Ophthalmol 1997;81:154-162.

56.Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, Harden PN.

Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002;13:260-264.

57.Howell WM, Ali S, Rose-Zerilli MJ, Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005;42:485–490.

58.Churchill AJ, Carter JG, Lovell HC, Ramsden C, Turner SJ, Yeung A, Escardo J, Atan D.

VEGF polymorphisms are associated with neovascular age-related macular degeneration.

Hum Mol Genet 2006;15:2955-2961.

59.Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-1235.

60.Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S.

A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-1639.

61.Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812-816.

62.Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-448.

63.Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY, Lee J, Kim SY, Goronzy JJ, Weyand CM, Kang YM. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 2004;43:1173-1177.

64.Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, Detmar M. Identification of a human VPF/VEGF 3'untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 1998;9:469-481.

65.Hangai M, He S, Hoffmann S, Lim JI, Ryan SJ, Hinton DR. Sequential induction of angiogenic growth factors by TNF-α in choroidal endothelial cells. J Neuroimmunol 2006;171:45-56.

66.Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A. Association of tumor necrosis factor(TNF) and class Ⅱ major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human monnuclear cells:A possible link to insulin-dependent diabetes mellitus. Eur J Immunol.

1993;23:224-231.

67.Sariban E, Imamura K, Luebbers R, Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 1988;81:1506-1510.

68.Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP.

Mapping the HLA association in Behcet’s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 2003;48:807-813.

69.Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in japanese.

Tissue Antigens 1998;51:605-612.

70.Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation.

Proc Natl Acad Sci USA 1997;94:3195-3199.

71.Yossuck P, Yan Y, Tadesse M, Higgins RD. Dexamethasone alters TNF-α expression in retinopathy. Mol Genet Metab 2001;72:164-167.

72.Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A. A common functional polymorphism(C→A substitution at position-863) in the promoter region of the tumor necrosis factor-α(TNF-α) gene associated with reduced circulating level of TNF-α. Hum Mol Genet 1999;8(8):1443-1449.

73.Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, Crivello A, Licata A, Valenza LM, Candore G, Craxi A, Almasio PL. IL-10 and TNF-α Polymorphisms and the recovery from HCV infection. Hum Immunol 2003;64:674-680.

74.Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kaji R, Kuno S. Tumor necrosis factor gene polymorphisms in patients with sporadic parkinson's disease. Neurosci Lett 2001;311:1-4.

75.Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease(IBD). Clin Exp Immunol 1996;103:391-396.

76.Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-406.

77.Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van de Gaer L, Dams L, Crusius JB, Garcia-Gonzalez A,van Oosten BW, Polman, CH, Pena AS. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72:149-153.

78.Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A, Sieper J, Braun J.

Low T cell production of TNF-alpha and IFN-gamma in ankylosing spondylitis: Its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001;60:36-42.

79.Sun D, Matsune S, Ohori J, Fukuiwa T, Ushikai M, Kurono Y. TNF-α and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 2005;32:243-249.

80.Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, Kim YJ, Lee HS. Interleukin- 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003;12:901-906.

81.Okayama N, Hamanaka Y, Suehiro Y, Hasui Y, Nakamura J, Hinoda Y. Association of interleukin-10 promoter single nucleotide polymorphisms -819 T/C and -592 A/C with aging. J Gerontol A Biol Sci Med Sci 2005;60:1525-1529.

82.Minton EJ, Smillie D, Smith P, Shipley S, McKendrick MW, Gleeson DC, Underwood JC, Cannings C, Wilson AG. Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes. Hum Immunol 2005;66:127-132.

83.Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006;314:989-992.

84.Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L, Ferrell RE, Gorin MB. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006;15:3206-3218.

85.Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, Weber BH.

Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227-3236.

86.Grassi MA, Fingert JH, Scheetz TE, Roos BR, Ritch R, West SK, Kawase K, Shire AM, Mullins RF, Stone EM. Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat 2006;27:921-925.

87.Gotoh N, Yamada R, Hiratani H, Renault V, Kuroiwa S, Monet M, Toyoda S, Chida S, Mandai M, Otani A, Yoshimura N, Matsuda F. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in japanese. Hum Genet 2006;120:139-143.

88.Marx J. Gene offers insight into macular degeneration. Science 2006;314: 405-405.

89.Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005;102:7227-7232.